Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Daiichi Sankyo
ImmunityBio, Inc.
Mayo Clinic
SOLTI Breast Cancer Research Group
Universitair Ziekenhuis Brussel
OncoNano Medicine, Inc.
Northwestern University
Duke University
Jiangsu HengRui Medicine Co., Ltd.
MultiVir, Inc.
BIND Therapeutics